Logo Lucerna-Chem
+41 41 420 9636

Regulatory Status

Article Status


Catalog Number Pack Size List Price* Promo Price* Quantity
HY-120874-5MG 5 mg 181,00 153,90 Add
HY-120874-10MMO 10 mM * 1 mL 197,00 167,50 Add
HY-120874-10MG 10 mg 299,00 254,20 Add
HY-120874-25MG 25 mg 656,00 557,60 Add
HY-120874-50MG 50 mg 935,00 794,80 Add
HY-120874-100MG 100 mg 1'485,00 1'262,30 Add

* CHF, excl. 7.7% VAT and shipping costs

Product Description

PF-06372865 is an orally active, α2/α3/α5 subtype-selective GABAA positive allosteric modulator (PAM). PF-06372865 is a high affinity ligand at GABAA receptors containing α1/α2/α3/α5 subunits (Kis of 2.9 nM, 21 nM, 134 nM for α2, α1 PAM, α2 PAM, respectively), with low affinity for α4/α6 subunits. PF-06372865 can across the blood-brain barrier (BBB). PF-06372865 has anxiolytic activity and has the potential for epilepsy.

Category Biochemicals
Supplier MedChem Express
Application Neuroscience-Neuromodulation
Regulatory Status RUO
Format Solubility: DMSO : 50 mg/mL (113.51 mM; Need ultrasonic)
Grade Clinical information: No Development Reported
Molecular Formula C22H21FN4O3S
Molecular Weight 440.49
CAS-Number [1614245-70-3]
Storage Conditions Please store the product under the recommended conditions in the Certificate of Analysis.
Product Line Research
Tech. Data Sheet View datasheet
Link To Supplier http://www.medchemexpress.com
Material Safety Data Sheet Download PDF
Call us

Customer Support
T +41 41 420 96 36
F +41 41 420 96 56

Business Hours
From Monday through Friday
08:00 – 12:00
13:00 – 17:00

Ask us

Technical Support

Business Development

Postal address
Lucerna-Chem AG
Abendweg 18
CH-6006 Luzern


If you have already subscribed to our newsletter and would like to update your details or cancel it, please click here.

© Copyright 2021 Lucerna-Chem AG, Switzerland